Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial agents for prevention of malodor in two-stage dental implants
IRCT20210705051795N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of chlorhexidine and tetracycline in halitosis (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Malodor after opening healing abutments. Started Aug 2021; status: completed.
02
Drugs
chlorhexidinetetracycline
03
Conditions
halitosis
Beyond the preview
Go deeper on IRCT20210705051795N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210705051795N1.